HarshabadSinghMD

Oncology • Boston, MA

Hematologic Oncology

Instructor in Medicine Dana-Farber Cancer Institute

Join to view full profile

Dr. Singh is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Singh's full profile

Already have an account?

Office
450 Brookline Ave
Dana-Farber Cancer Institute
Boston, MA 02215

Education & Training

Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2014 - 2015
Massachusetts General HospitalResidency, Internal Medicine, 2011 - 2014
Government Medical College ChandigrahClass of 2009

Certifications & Licensure

MA State Medical License 2015 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Distinct molecular and clinical features of specific variants of KRAS codon 12 in pancreatic adenocarcinoma.
Bach Ardalan, Aaron Ciner, Yasmine Baca, Andrew Hinton, Sourat Darabi
Clinical Cancer Research. 2025-01-16
A Phase I Trial of Trebananib, an Angiopoietin 1 and 2 Neutralizing Peptibody, Combined with Pembrolizumab in Patients with Advanced Ovarian and Colorectal Cancer.
Brandon M Huffman, Osama E Rahma, Kevin Tyan, Yvonne Y Li, Anita Giobbie-Hurder
Cancer Immunology Research. 2025-01-09
Crypt density and recruited enhancers underlie intestinal tumour initiation.
Liam Gaynor, Harshabad Singh, Guodong Tie, Krithika Badarinath, Shariq Madha
Nature. 2025-01-08

Press Mentions

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer in TrialMarch 14th, 2024